a public good project by the
Synthesis
Company
of California

© 2026

David M. Weiner | doi.page

0 works0 citations0 h-index

David M. Weiner

National Institutes of Health(US)National Institute of Allergy and Infectious Diseases(US)Office of Extramural Research(US)

Publications by Year

Research Areas

Receptor Mechanisms and Signaling, Cutaneous lymphoproliferative disorders research, Neurotransmitter Receptor Influence on Behavior, Lymphoma Diagnosis and Treatment, Neuroscience and Neuropharmacology Research

Most-Cited Works

→ D1 and D2 dopamine receptor mRNA in rat brain.(1991)484 cited
→ Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia.(1990)480 cited
→ Human dopamine D1 receptor encoded by an intronless gene on chromosome 5(1990)465 cited
→ Priorities in Parkinson's disease research(2011)428 cited
→ The role of M1 muscarinic receptor agonism of N-desmethylclozapine in the unique clinical effects of clozapine(2004)249 cited
→ 5-Hydroxytryptamine2A Receptor Inverse Agonists as Antipsychotics(2001)201 cited
→

Pharmacological and Behavioral Profile of N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl) Carbamide (2 R,3 R)-Dihydroxybutanedioate (2:1) (ACP-103), a Novel 5-Hydroxytryptamine2A Receptor Inverse Agonist

(2006)

197 cited

→ Intrinsic Efficacy of Antipsychotics at Human D2, D3, and D4 Dopamine Receptors: Identification of the Clozapine Metabolite N-Desmethylclozapine as a D2/D3 Partial Agonist(2005)181 cited

→ Evidence for a Model of Agonist-induced Activation of 5-Hydroxytryptamine 2A Serotonin Receptors That Involves the Disruption of a Strong Ionic Interaction between Helices 3 and 6(2002)172 cited

→ RNA Editing Induces Variation in Desensitization and Trafficking of 5-Hydroxytryptamine 2c Receptor Isoforms(2004)159 cited